DLB - Dolby Laboratories EPS beats by $0.02 misses on revenue
Dolby Laboratories (NYSE:DLB): FQ4 Non-GAAP EPS of $0.58 beats by $0.02; GAAP EPS of $0.42 beats by $0.07. Revenue of $285.03M (+5.1% Y/Y) misses by $14.92M. Shares -6.23%. Press Release FQ1 2022 Outlook: Total revenue is estimated to range from $345M-375M, Gross margin percentages are anticipated to range from 90% to 91% on a GAAP basis and from 91% to 92% on a non-GAAP basis, Diluted earnings per share is anticipated to range from $0.71 to $0.86 on a GAAP basis and from $0.98 to $1.13 on a non-GAAP basis. 2022 Outlook: Total revenue is estimated to range from $1.34B--1.4B, Operating margin percentages are anticipated to range from 24% to 26% on a GAAP basis and from 34% to 36% on a non-GAAP basis, Diluted earnings per share is anticipated to range from $2.53 to $3.03 on a GAAP basis and from $3.52 to $4.02 on a non-GAAP basis.
For further details see:
Dolby Laboratories EPS beats by $0.02, misses on revenue